首页> 外文期刊>Antiviral Research >Targeting the pseudorabies virus DNA polymerase processivity factor UL42 by RNA interference efficiently inhibits viral replication
【24h】

Targeting the pseudorabies virus DNA polymerase processivity factor UL42 by RNA interference efficiently inhibits viral replication

机译:通过RNA干扰靶向伪狂犬病病毒DNA聚合酶持续性因子UL42可有效抑制病毒复制

获取原文
获取原文并翻译 | 示例
           

摘要

RNA interference (RNAi) is a conserved gene-silencing mechanism in which small interfering RNAs (siRNAs) induce the sequence-specific degradation of homologous RNAs. It has been shown to be a novel and effective antiviral therapy against a wide range of viruses. The pseudorabies virus (PRV) processivity factor UL42 can enhance the catalytic activity of the DNA polymerase and is essential for viral replication, thus it may represent a potential drug target of antiviral therapy against PRV infection. Here, we synthesized three siRNAs (siR-386, siR-517, and siR-849) directed against UL42 and determined their antiviral activities in cell culture. We first examined the kinetics of UL42 expression and found it was expressed with early lcinetics during PRV replication. We verified that siR-386, siR-517, and siR-849 efficiently inhibited UL42 expression in an in vitro transfection system, thereby validating their inhibitory effects. Furthermore, we confirmed that these three siRNAs induced potent inhibitory effects on UL42 expression after PRV infection, comparable to the positive control siRNA, siR-1046, directed against the PRV DNA polymerase, the UL30 gene product, which is essential for virus replication. In addition, PRV replication was markedly reduced upon downregulation of UL42 expression. These results indicate that UL42-targeted RNAi efficiently inhibits target gene expression and impairs viral replication. This study provides a new clue for the design of an intervention strategy against herpesviruses by targeting their processivity factors. (C) 2016 Elsevier B.V. All rights reserved.
机译:RNA干扰(RNAi)是一种保守的基因沉默机制,其中小的干扰RNA(siRNA)诱导同源RNA的序列特异性降解。已经显示出它是针对多种病毒的新颖有效的抗病毒疗法。伪狂犬病病毒(PRV)持续性因子UL42可以增强DNA聚合酶的催化活性,并且对于病毒复制至关重要,因此它可能代表抗PRV感染的抗病毒治疗的潜在药物靶标。在这里,我们合成了针对UL42的三种siRNA(siR-386,siR-517和siR-849),并确定了它们在细胞培养中的抗病毒活性。我们首先检查了UL42表达的动力学,并发现它在PRV复制过程中以早期胰蛋白酶表达。我们验证了siR-386,siR-517和siR-849在体外转染系统中有效抑制了UL42的表达,从而验证了它们的抑制作用。此外,我们证实这三种siRNA诱导了PRV感染后对UL42表达的强抑制作用,相当于针对PRV DNA聚合酶UL30基因产物的阳性对照siRNA siR-1046,这对于病毒复制至关重要。此外,PRV复制在UL42表达下调后明显减少。这些结果表明,以UL42为靶标的RNAi可有效抑制靶标基因表达并损害病毒复制。这项研究为针对疱疹病毒的生产力因素设计了一种干预策略设计的新线索。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号